# Olivier Rosmorduc

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/olivier-rosmorduc/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,920 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 50 |
| i10-index | 106 |
| Last Known Institution | Université Paris-Saclay |
| OpenAlex ID | https://openalex.org/A5020985866 |
| ORCID iD | https://orcid.org/0000-0002-6695-3088 |
| Works | 256 |

## Researcher papers

- [Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-patients-with-advanced-hepatocellular-carcinoma-previously/)
- [Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma](https://scholariq.org/papers/impact-of-combined-selective-internal-radiation-therapy-and-sorafenib-on/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Researcher university

- [Université Paris-Saclay](https://scholariq.org/institutions/universite-paris-saclay/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.